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Abstract: A randomized two-arm prospective superiority trial tested the efficacy of a novel structured and monitored nutrition (bi-weekly counselling for individualized energy and high dairy
protein diet) and exercise program (walking goal of 10,000 steps/day) (intervention) compared to
usual care (control) in pregnant women to achieve gestational weight gain (GWG) within current
recommendations. Women recruited in communities in southern Ontario, Canada were randomized
at 12–17 weeks gestation with stratification by site and pre-pregnancy BMI to intervention (n = 119)
or control (n = 122). The primary outcome was the proportion of women who achieved GWG within
the Institute of Medicine recommendations. Although the intervention compared to control group
was more likely to achieve GWG within recommendations (OR = 1.51; 95% CI (0.81, 2.80)) and
total GWG was lower by 1.45 kg (95% CI: (−11.9, 8.88)) neither reached statistical significance. The
intervention group achieved significantly higher protein intake at 26–28 week (mean difference (MD);
15.0 g/day; 95% CI (8.1, 21.9)) and 36–38 week gestation (MD = 15.2 g/day; 95% CI (9.4, 21.1)) and
higher healthy diet scores (22.5 ± 6.9 vs. 18.7 ± 8.5, p < 0.005) but step counts were similar averaging
6335 steps/day. Pregnancy and infant birth outcomes were similar between groups. While the
structured and monitored nutrition with counselling improved diet quality and protein intake and
may have benefited GWG, the exercise goal of 10,000 steps/day was unachievable. The results can
inform future recommendations for diet and physical activity in pregnancy.
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1. Introduction
Despite the available guidelines on gestational weight gain (GWG) from the Institute
of Medicine since 2009 [1], excess GWG is highly prevalent in women across all prepregnancy body mass index (pBMI) categories in both Canada and the United States [2,3].
In observational studies, excessive GWG and pregravid obesity were associated with
greater risk of adverse perinatal outcomes [4–8] and risk of infant macrosomia or large-forgestational age rises with maternal pregravid obesity and excessive GWG [9–12].
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The experimental intervention in the Be Healthy in Pregnancy (BHIP) randomized
controlled trial (RCT) [13] was grounded in a synthesis of existing systematic reviews of
RCTs with varying intervention strategies that suggested the most convincing approach to
achieve reduction in GWG was a combination of physical activity and individualized diet
counselling, preferably in combination with weight monitoring [14–16].
The primary objective of the BHIP study was to determine if introducing a structured
and monitored nutrition and exercise program (intervention) in early pregnancy compared
with usual prenatal care (control) increased the likelihood of attaining GWG within the IOM
guidelines (outcome) over the pregnancy period. We hypothesized that the experimental
combined structured and monitored Nutrition + Exercise intervention compared with usual
care would increase the percentage of pregnant women who achieved a GWG within IOM
recommendations overall and for each pre-pregnancy BMI category and site. Other prespecified outcomes included comparison of pregnancy and birth outcomes and maternal
metabolic health between intervention and control groups.
2. Materials and Methods
2.1. Study Design, Data Collection, and Ethical Aspects
The BHIP study was a two-arm, two-site prospective superiority trial with 1:1 allocation ratio to either the intervention group (i.e., Nutrition + Exercise with counselling and
monitoring) or the control group (usual care as per Health Canada recommendations) from
early pregnancy to birth. Ethics approval was obtained from the Research Ethics Boards
of Hamilton Health Sciences (REB Project#12-469), Western University, London (HSREB
103272), and Joseph Brant Hospital, Burlington (JBH 000-018-14) in Ontario, Canada. The
trial was registered in 2012 [17].
2.2. Recruitment, Randomization, and Followup
Healthy pregnant women who represented all pBMI categories except extreme obesity
(>40 kg/m2 ) were recruited from community health care clinics in Hamilton, Burlington
and London, Ontario between 12 and 17 weeks of gestation from January 2013 to April 2018
as previously detailed in the study protocol paper [1]. Eligibility criteria were screened at
the first contact and the baseline visit [13].
Block randomization to the two study arms was conducted at the second visit to the
study center and was stratified by study site and pBMI category used by IOM [1] as detailed
previously [13]. The study was open-label with blinded endpoints due to the nature of the
intervention as detailed [13].
All participants received standard care delivered by their health care practitioner
(physician or midwife) during pregnancy. After enrolment, all participants received counselling and hard copies of the advice from Health Canada at the time of the trial as published
online [18–20]. The primary caretaker of each participant also received mailed copies of the
same materials. A $25 Canadian grocery gift card was available for all participants on three
occasions when dietary and accelerometry data were collected.
2.2.1. Intervention
The multi-component intervention strategy included the specific active intervention of
a high protein dairy diet and individualized energy intake found effective in our previous
two studies in non-pregnant women [21,22] and proven reasonable by our qualitative
testing for feasibility [23]. In-person counselling occurred weekly or biweekly from early in
the second trimester (14–17 weeks gestation) until the end of pregnancy as detailed [13]. The
study nutritionist counselled the participants on their individual dietary goals, providing
recipes and diet plans suited to meet energy requirements. The individualized goals were
based on providing 25% of their energy intake from protein of which 50% of the protein was
derived from dairy foods as approximately 4–6 servings daily of low-fat dairy, such as milk,
cottage cheese, and yogurt according to each participant’s preference. The diet plan was set
to each individual’s calculated Estimated Energy Requirements (EER) using the equations
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in the Dietary Reference Intake report for normal and overweight pregnant women based
on their size, age, and physical activity levels, with additional energy goals added as
pregnancy progressed [24]. Several strategies to promote adherence to the diet intervention
were included such as provision of low-fat dairy foods as per participant preference
as detailed previously [13]. For the walking-based exercise program, participants first
completed a validated activity questionnaire which was reviewed by a certified exercise
physiologist to assess participants’ activity levels at baseline. Participants were encouraged
to follow guidelines from the PARmed-X for Pregnancy [22], walking 3–4 times each week
for 25 min a session, increasing their walking time by 2 min a week until they reached
40 min. At each study visit, the research assistant walked with the participant for 30 to
40 min around campus or within the medical center/hospital during inclement weather.
The goal was to walk 10,000 steps/day; any daily form of physical activity counted towards
the step count, including walking sessions at study visits accompanied by research staff
and daily habitual activities, and were measured through use of a pedometer with records
kept on pedometer logs that were reviewed at each study visit [13].
2.2.2. Usual Care
The control group received usual care provided by their primary care provider and
only returned to the study site for outcome measurements at 26–28 and 36–38 weeks of
gestation. As a retention strategy, control participants were invited to join a focus group
in the second trimester led by a midwife, with topics including pain relief options during
labor and breastfeeding techniques.
2.3. Outcomes and Measurements
The primary outcome was the proportion of women who were within the appropriate
GWG for pBMI category using the IOM 2009 recommendations for total GWG and GWG per
week over the second and third trimesters of pregnancy [1]. Body weight was measured by
trained research assistants using a Tanita Body Composition Analyzer BF-350 scale (Tanita,
Arlington Heights, IL, USA) and GWG calculated as previously described [13].
Demographic information was obtained at baseline using a standard questionnaire and
screening for depression score used the Edinburgh Depression Scale [25]. Diet assessment
was completed at 12–17, 26–28, and 36–38 weeks gestation and included a 21-item food
frequency questionnaire (FFQ) adapted from the validated PrimeScreen FFQ [26] to derive
a score for healthy dietary practices and a 3-day food intake record to determine protein and
energy intakes [13]. Physical activity and exercise behaviors were assessed during the same
3 days using a SenseWear armband tri-axis accelerometer (Model MF-SW:BodyMedia Inc.,
Pittsburgh, PA, USA) and analyzed to obtain step count, energy expenditure, and minutes
of activity level using SenseWear Professional 8.1 Software (BodyMedia Inc., Pittsburgh,
PA, USA).
Obstetrical outcomes obtained from medical charts or by self-report by the participants
included delivery mode, diagnosis of gestational diabetes mellitus (GDM defined as blood
glucose of >7.2 mmol/L 2 h after a 75 g oral glucose tolerance test), and pre-eclampsia.
At 12–17 and 36–38 weeks gestation, blood pressure was measured and fasting blood
samples obtained for profiles of lipids, glucose, C-reactive protein, and hormones leptin
and adiponectin by methods previously detailed [13]. At these two time points and at
26–28 weeks gestation, skinfold thickness was measured in triplicate (Harpenden Skinfold
Caliper, Baty International, West Sussex, UK) by trained staff on the right-hand side of the
body at four sites—subscapular, triceps, biceps, and supra-iliac crest for which triplicate
values were averaged and sum of skinfold thickness (SFT) calculated. Percent body fat was
estimated from leg-to-leg body impedance by using the Tanita Body Composition Analyzer
BF-350 scale (Tanita, Arlington Heights, IL, USA).
Pre-specified infant outcomes extracted from medical charts included gestational age,
birth weights which were categorized as small, appropriate, or large for gestational age [27],
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length, head circumference, 1- and 5-min Apgar scores, complications related to birth, and
feeding practices at birth.
2.4. Sample Size and Statistical Analysis
The proposed sample size of 155 participants per treatment group was based on the
test of the null hypothesis that the percentages of women with GWG within IOM guidelines
in the two populations (intervention and control) are equal as detailed in our research
design paper [13]. We revised our target sample size based on our a priori calculation to
a sample size of 111 per group corresponding to 30% of women in the treatment group
having a GWG exceeding the IOM recommendations compared to 65% in the control group.
With the revised sample size (i.e., assuming a 1:1 allocation ratio), the study would have
power of 80% to yield a statistically significant result assuming a binomial distribution
(using an intention-to-treat principle for the analysis) of the difference between percentages
of women with GWG within IOM guidelines at alpha = 0.05.
Data were entered into an online Research Electronic Data Capture (REDCap) service
hosted at McMaster University) [13]. Descriptive statistics of participant baselines characteristics and outcome variables (both primary and secondary) were reported as detailed
previously [13]. The primary analysis for all outcomes was intention to treat (ITT) for
119 intervention and 122 control group participants with imputed data for missing values
(28). Complete case analysis included 101 intervention and 104 control group participants
who had outcome measurements for the primary outcome (GWG) available at the end
of pregnancy.
Multivariable regression analyses were used to determine the intervention effect on
each outcome of interest, adjusting for stratification variables: study site and pre-pregnancy
BMI category. Due to a low number of individuals in the underweight category (n = 4),
these individuals were grouped with normal weight category.
For the primary outcome, GWG within IOM guidelines (yes/no), both a binary regression model and logistic regression model were created. The adjusted odds ratio, 95%
CI, and p value were computed using a logistic regression model (distribution = binomial,
link = logit).
For continuous outcomes, linear regression was performed. Outcomes where the
normality assumption was not met were transformed (using natural log [Ln] or square
root transformations) before being used in a model. For the remaining binary outcomes,
logistic regression analyses were performed. For all models, the results are expressed as an
estimate of the adjusted mean difference for continuous outcomes (adjusted odds ratio (OR)
for binary outcomes), corresponding two-sided 95% confidence intervals, and associated
p-values.
For the PrimeScreen dietary assessment scores contrasted between allocation groups
over time, generalized estimating equations (GEE) assuming autoregressive (AR(1)) correlation structure were used to account for correlated repeated outcome data within a
participant over time. A normal model with identity link function was used. Analysis was
controlled for maternal pBMI and study site.
Sensitivity analysis was performed using per protocol analysis and complete case
analysis for all outcomes. Individuals were included for per protocol analyses if they had
reported gestational weight gain values during their third visit; results were reported based
on analysis of imputed data. Individuals included for complete case analysis were based on
data available for each outcome and independent variables adjusted in the model; results
were reported based on analysis of non-imputed data.
For all subgroup analyses, the treatment effect and confidence intervals for each site
and each pre-pregnancy BMI level, along with the interaction p value are reported. Forest
plots were constructed for the primary outcomes.
All statistical tests were performed using two-sided tests at the 0.05 level of significance.
All analyses were performed using SAS software Version 9.4 (SAS Institute Inc., Cary, NC,
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USA) and SPSS 25 (Chicago, IL, USA). Forest plots were created in Stata software (Version
15.0; College Station, TX, USA)
3. Results
3.1. Participant Recruitment and Characteristics
Recruitment occurred between January 2013 and April 2018 [13] with a total of
693 women screened by phone of whom 123 (17.7%) did not meet eligibility criteria, and
296 (42.7%) declined to participate for reasons noted in Figure 1. Challenges to recruitment
of participants in the early stages of the study were detailed in the protocol paper [13].
Of 274 women who consented and attended the first visit, 33 were not randomized because they failed to return for the second visit as noted in Figure 1. After randomization,
two in each treatment arm declined to initiate the study; after study initiation, 17 in the
intervention group and 15 in the control group withdrew for reasons noted in Figure 1.
At study entry, participant characteristics were well balanced by randomized groups
with the majority being of European descent, university educated, family income above
$75,000 Canadian, and married/common law (Table 1). About 30% were categorized by
pBMI as overweight and about 18% as obese (Table 1).
Table 1. Demographic characteristics of participants at 12–17 week gestation. Values are raw data.
Intervention
(n = 119)

Control
(n = 122)

Mean (SD) 1

Mean (SD)

31.6 (3.9)

31.3 (4.3)

Gestational age at randomization (week)

13.75 (1.75)

13.60 (1.61)

Maternal weight, kg

72.4 (13.4)

71.8 (13.1)

25.7 (4.5)

25.3 (4.6)

n (%)

n (%)

Pre-pregnancy BMI
category
Underweight (<18.5)
Normal weight (18.5–24.9)
Overweight (25.0–29.9)
Obese (30.0–39.9)

2 (1.7)
61 (51.3)
34 (28.6)
22 (18.5)

2 (1.6)
62 (50.8)
37 (30.3)
21 (17.2)

University education
Missing

114 (99.1)
4

114 (95.8)
3

Race/ethnicity
European descent
Mixed/other
Missing

105 (88.2)
14 (11.8)
0

107 (87.7)
13 (10.7)
2

Total family income
<$45,000
$45,000–$74,999
>$75,000
Missing (=Unknown)

7 (5.9)
19 (16.2)
91 (77.8)
2

10 (8.9)
25 (22.1)
78 (69.0)
9

Married/living with significant other
Missing

117 (98.3)
0

114 (96.6)
4

Nulliparous
Missing

58 (49.15)
1

56 (47.46)
4

Study site (city)
Western U (London)
McMaster U (Hamilton/Burlington)

38 (31.9)
81 (68.1)

39 (32.0)
83 (68.0)

Demographic Characteristic

Maternal age (year)

Pre-pregnancy BMI

2

(kg/m2 )

(kg/m2 )
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Table 1. Cont.
Demographic Characteristic

Intervention
(n = 119)

Control
(n = 122)

Physical and Metabolic Measures

Mean (SD)

Mean (SD)

Maternal fat mass
Bioelectrical impedence (BIA), % body fat
Missing
Sum of skinfolds (SFT) (mm)
Missing

33.98 (6.55)
8
72.28 (23.32)
3

34.11 (7.14)
3
72.07 (26.15)
4

Missing

109.20 (10.43)
2
68.96 (7.54)
2

108.95 (10.49)
3
69.24 (7.69)
3

Missing

2085 (312)
11

2084 (356)
11

Missing

7043 (2655)
11

6587 (2545)
11

Missing

4.34 (3.13)
1

4.24 (2.79)
1

4.84 (0.60)
13
1.29 (0.60)
13
5.42 (1.18)
13
1.86 (0.44)
13
2.97 (0.81)
14
31.76 (25.31)
9
42.43 (34.81)
10
8.19 (3.17)
9
6.29 (4.86)
9

4.77 (0.47)
10
1.28 (0.42)
10
5.24 (0.97)
10
1.81 (0.39)
10
2.85 (0.71)
10
30.14 (25.54)
7
40.88 (29.55)
8
8.45 (4.10)
7
6.21 (5.65)
8

Maternal blood pressure (mmHg)
Systolic
Missing
Diastolic
Maternal physical activity
Energy expenditure (kcal/day)
Average daily step count
Maternal depression score
Maternal metabolic outcomes
Fasting glucose (mmol/L)
Missing
Triglycerides (mmol/L)
Missing
Total cholesterol (mmol/L)
Missing
HDL-cholesterol (mmol/L)
Missing
LDL-cholesterol (mmol/L)
Missing
Leptin (ng/mL)
Missing
Insulin (pmol/L)
Missing
Adiponectin (µg/mL)
Missing
CRP (mg/L)
Missing
1

SD = Standard Deviation; 2 BMI = Body Mass Index.
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Figure 1. CONSORT diagram for recruitment, randomization, and follow-up of participants.
Figure 1. CONSORT diagram for recruitment, randomization, and follow-up of participants.
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vention
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(ITT)(ITT)
analysis,
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not statistically
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= 1.51;
95%
0.81,
2.80)(Figure
(Figure2).
2).This
This observation
observation was
statistically
significant
(OR(OR
= 1.51;
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0.81,
2.80)
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perprotocol
protocol
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(OR
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across analyses (Figure 2). The total GWG (ITT: MD = −1.45; 95% CI: −1.79, 8.88 kg) was
lower but not significantly different in the intervention compared to the control group
analyses (Figure 2). The total GWG (ITT: MD = −1.45; 95% CI: −1.79, 8.88 kg) was lower
(Figure 2).
but not significantly different in the intervention compared to the control group (Figure 2).

Figure
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2).In
Inthe
thenormal
normalBMI
BMIcategory,
category,about
about50%
50%ofofthe
theintervention
interventionand
and
34%
34%ofofthe
thecontrol
controlgroup
grouphad
hadGWG
GWGwithin
withinthe
theIOM
IOMguidelines
guidelines(Table
(Table2).
2).In
Inthe
theoverweight
overweight
and
andobese
obeseBMI
BMIcategories,
categories,only
only33to
to16%
16%of
ofwomen
women met
met GWG
GWG recommendations
recommendations (Table
(Table2).
2).
Both
GWG
per
week
and
total
GWG
were
similar
between
intervention
and
control
groups
Both GWG per week and total GWG were similar between intervention and control
within
categories
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Table 2. Gestational weight gain (GWG) outcomes in intervention compared to control group across
pre-pregnancy body mass index (pBMI) categories (intention-to-treat sensitivity analysis).
Intervention
(n = 119) 1
% Participants
Within IOM guidelines for
GWG/week
49.2%
Normal Weight 4
10.3%
Overweight 4
5.9%
Obese 4
GWG per week
(kg/week) 5
Normal Weight 4
IOM recommendation
(0.42 kg/week)
Overweight 4
IOM recommendation
(0.28 kg/week)
Obese 4
IOM recommendation
(0.22 kg/week)
Total GWG (kg)
Normal Weight 4
IOM recommendation
(11.5–16.0 kg)
Overweight 4 IOM
recommendation
(7.0–11.5 kg)
Obese 4
IOM recommendation
(5.0–9.0 kg)

Intervention Effect

Control
(n = 122) 1
% Participants

OR 2
(95% CI) 3

34.4%
3.1%
15.8%

1.92 (0.93, 4.00)
1.38 (0.23, 8.27)
0.26 (0.02, 2.74)

Mean Difference
(95% CI) 3

Interaction
p

.
0.739
0.110

Mean (SD)

Mean (SD)

n = 58
0.48 (0.15)

n = 61
0.49 (0.16)

−0.03 (−0.08, 0.02)

.

n = 30
0.48 (0.13)

n = 32
0.53 (0.15)

−0.01 (−0.07, 0.07)

0.962

n = 17
0.45 (0.16)

n = 19
0.38 (0.22)

−0.22 (−2.25, 1.81)

0.813

n = 58
11.02 (3.40)

n = 61
11.43 (3.67)

−0.69 (−1.94, 0.55)

.

n = 30
11.30 (3.11)

n = 32
12.22 (3.69)

−0.33 (−2.02, 1.36)

0.764

n = 17
10.02 (3.67)

n = 19
8.92 (5.34)

−0.40 (−3.60, 4.41)

0.539

1

14 values missing from intervention; 10 missing from control. 2 OR = odds ratio. 3 CI = confidence interval.
Underweight to normal weight (≤24.9), overweight (25.0–29.9), obese (≥30.0–39.9). Underweight and normal
weight were grouped together due to a low number of observations in the underweight category (n = 4). 5 Calculated over the second and third trimesters of pregnancy. All analyses adjusted for study site (Hamilton, London)
but not PBMI as the analysis was for prevention effect across pBMI categories.
4

3.3. Pre-Specified Pregnancy and Birth Outcomes
Outcomes of Cesarean section, pre-eclampsia, and gestational diabetes (GDM) were
more frequent in the control than intervention group but the differences were not statistically significant (Figure 3). Regression analysis could not be performed on all outcomes
due to insufficient events of GDM (<5% participants) and pre-eclampsia (<2% participants)
due in part to missing data not recorded on the pregnancy birth record. Impaired fasting
glucose (defined as blood glucose > 5.1 mmol/L) was similar between treatment groups
(Figure 3) and occurred in about 14% of women in both groups.
No intervention effect was observed for mean difference in birth weight (MD = 138 g;
95% CI: −218, 494 g) or gestational age (MD = 0.26; 95% CI: −1.27, 1.80 week) (Table 3). Most
(82–87%) infants had birth weights appropriate for gestational age (10th–90th percentile
for weight), <8% were small for gestational age (<10th percentile) and <10% were large for
gestational age (>90% percentile) (Table 3). Only five infants were born prematurely, two in
the intervention group and three in the standard care group.

Nutrients
FOR PEER REVIEW
Nutrients 2022,
2022, 14, x810

1010ofof 19
19

Figure 3. Forest plots of intervention effect for binary pre-specified pregnancy outcomes by intentionFigure 3. Forest plots of intervention effect for binary pre-specified pregnancy outcomes by
to-treat, per protocol, and complete case analysis adjusted for study site and maternal pre-pregnancy
intention-to-treat, per protocol, and complete case analysis adjusted for study site and maternal preBMI category.
= odds OR
ratio;
CI = confidence
interval Allinterval
analyses
adjusted
site (Hamilton,
pregnancy
BMIOR
category.
= odds
ratio; CI = confidence
All
analysesforadjusted
for site
London)
and
pre-pregnancy
BMI
(preBMI)
categories:
underweight
to
normal
weight
(≤24.9),
over(Hamilton, London) and pre-pregnancy BMI (preBMI) categories: underweight to normal
weight
weight overweight
(25.0–29.9), (25.0–29.9),
obese (≥30).obese
Due (≥30).
to a very
events,of
adjusted
regression
analyses
(≤24.9),
Duelow
to a number
very lowofnumber
events, adjusted
regression
could notcould
be performed
on operative
vaginal delivery.
analyses
not be performed
on operative
vaginal delivery.

Table 3. Pre-specified infant birth outcomes at birth in intervention compared to control groups by
Table 3. Pre-specified infant birth outcomes at birth in intervention compared to control groups by
intention-to-treat (ITT) analysis. Values for intervention and control are mean (SD) of raw data with
intention-to-treat
(ITT) analysis. Values for intervention and control are mean (SD) of raw data with
missing
values noted.
missing values noted.

Intervention
Intervention
n = 119
n = 119

3553

Birth weight (g)

3476

Missing

3553(508)
(508)
12
12

3476(456)
(456)
11
11

Missing
Missing

39.76
(1.30)
(1.30)
13 13

39.72
(1.29)
(1.29)
10 10

Birth weight (g)

Missing

Gestational age (weeks)
Gestational age (weeks)

Birth
weight category, n (%)
Birth weight category, n (%) 2

Control
Control
n = 122
n = 122

39.76

39.72

Intervention Effect by ITT
1
Intervention
Effect by (95%CI)
ITT
Mean Difference
p
Mean Difference (95%CI) 1

138.10

138.10 493.93)
(−217.72,
(−217.72, 493.93)

0.26
0.26
(−1.27, 1.80)

(−1.27, 1.80)

2

Small for gestational age < 10%
Small for gestational age < 10%

Appropriate
forgestational
gestational
10–90%
Appropriate for
ageage
10–90%
Large for gestational age > 90%
Large
for gestational age > 90%

8

8
(7.55)
(7.55)
87 87
(82.08)
(82.08)
11 11
(10.38)

(10.38)

7

7
(6.31)
(6.31)
97 97
(87.39)
(87.39)
7 7
(6.31)

(6.31)

2

2

p

0.432
0.432

0.718

0.718
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Table 3. Cont.
Intervention
n = 119

Control
n = 122

Missing

13

11

Missing

3
(2.91)
16

16

Missing

8.92
(0.05)
17

8.93
(0.40)
16

Birth trauma, n (%)

5-min Apgar score

Intervention Effect by ITT
Mean Difference (95%CI) 1

p

2

0

2

1

OR = odds ratio; CI = confidence interval. 2 Due to a low number of events, adjusted regression analyses could
not be performed on the categorical outcomes of SGA/AGA/LGA, birth trauma, and 5-min Apgar score. All
analyses adjusted for site (Hamilton/Burlington, London) and pre-pregnancy BMI categories: underweight to
normal weight (BMI ≤ 24.9), overweight (BMI = 25.0 – 29.9), obese (BMI = 30.0 – 39.9).

3.4. Pre-Specified Maternal Health Outcomes
At baseline measures of adiposity, blood pressure, fasting glucose, blood lipid profiles,
and leptin, insulin, and adiponectin were similar between allocation groups (Table 1). At
36–38 weeks gestation blood pressure was similar between groups (Table 4). Hypertension,
defined as SBP > 140 mmHg and DBP > 90 mmHg [24], was observed in 2 women in the
intervention and 2 women in the control group at late pregnancy. No intervention effect
was observed for maternal depression score at the end of pregnancy (Table 4). At late
pregnancy, after about 23–25 weeks of intervention, the mean difference for both sum of
skinfolds (MD = 1.5 mm; 95% CI: −31.02, 34.11 mm) and % body fat by BIA (MD = 0.25%;
95% CI: −0.65, 1.15%) were similar between groups (Table 4).
Table 4. Pre-specified maternal health outcomes at 36–38 weeks gestation in intervention compared
to control groups. Values are mean (SD) unless otherwise noted.
Intervention
(n = 119)
n (%)

Outcome

Control
(n = 122)
n (%)

Intervention Effect
Complete Case Analysis
Mean Difference
(95% CI) 1

p

ITT Analysis
Mean Difference
(95% CI)

p

Maternal Fat Mass
% body fat by BIA
Missing
Sum of Skinfolds (mm)
Missing

38.1 (6.1)

37.7 (5.9)

24

26

77.1 (22.9)

75.8 (24.3)

22

26

113 (12)

113 (11)

22

26

73 (9)

74 (9)

22

26

3.0 (1,5)

3.0 (1,6)

0.09
(−0.76, 0.95)
55
−1.07
(4.86, 2.72)
49

0.829

0.579

0.25
(−0.65, 1.15)
−
1.55
(−31.01, 34.11)
−

0.582

0.919

Maternal Blood Pressure
(mmHg)
Systolic
Missing
Diastolic
Missing
Maternal depression score,
median
Missing

23
1

25
2

−0.40
(−3.28, 2.48)
49
−1.17
(−3.38, 1.05)
49
−0.06
(−0.30, 0.18) 2
50

0.784

0.300

0.609

−2.43
(−11.78, 6.91)
−
−2.64
(−8.55, 3.26)
−0.10
(−0.32, 0.13) 2
−

0.593

0.371

0.400

CI = confidence interval. Regression analysis based on square root transformation of outcome. All analyses
adjusted for site (Hamilton/Burlington, London) and pre-pregnancy BMI categories: underweight to normal
weight (BMI ≤ 24.9), overweight (BMI = 25.0–29.9), obese (BMI ≥ 30.0–39.9).
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Metabolic profiles including blood glucose, HDL, LDL, total cholesterol, triglycerides,
leptin, insulin, adiponectin, and CRP were similar between groups at 36–38 weeks gestation
by ITT analysis (Table 5). By complete case analysis, the intervention compared to control
group had significantly lower LDL (MD = −0.31 mmol/L; 95%CI: −0.57, −0.06) and total
cholesterol (MD = −0.41; 95% CI: −0.72, −0.09 mmol/L), and higher CRP (MD = 0.21;
95% CI: 0.01, 0.42 mg/L) (Table 5).
Table 5. Pre-specified maternal metabolic profiles at 36–38 weeks gestation for intervention and
control groups based on fasting blood samples.
Group Mean (SD)
Median (Q1, Q3) 1

Intervention Effect
Complete Case Analysis

Intervention
n = 119

Control
n = 122

Mean
Difference
(95% CI)

Missing

4.6
(0.5)
31

4.6
(0.5)
26

−0.04
(−0.17, 0.08)
61

Missing

1.88
(0.44)
30

1.87
(0.46)
28

−0.03
(−0.12, 0.07)
62

Missing

4.00
(1.11)
31

4.17
(1.09)
30

−0.31
(−0.57, −0.06)
66

2.53
(0.80)
30

2.66
(0.79)
28

−0.18
(−0.36, 0.01)
62

Missing

7.03
(1.38)
30

7.26
(1.33)
28

−0.41
(−0.72, −0.09)
62

Missing

52.08
(34.06, 82.36)
27

47.95
(32.16, 74.31)
25

<0.01
(−0.15, 0.15) 2
56

Missing

29.83
(15.97, 49.35)
26

30.32
(15.47, 54.63)
25

−1.37
(−6.67, 3.92)
54

Missing

6.97
(2.62)
26

7.32
(3.21)
25

0.02
(−0.55, 0.58)
54

Missing

4.29
(2.39, 7.37)
26

4.53
(1.92, 7.36)
25

0.21
(<0.01, 0.42) 2
55

Metabolite

Glucose, mmol/L

HDL, mmol/L

LDL, mmol/L

Triglycerides, mmol/L
Missing
Total cholesterol, mmol/L

Insulin, pmol/L

Leptin, ng/mL

Adiponectin, ug/mL

CRP, mg/L

ITT Analysis

p

Mean
Difference
(95% CI)

p

0.481

−0.02
(−0.16, 0.12)

0.787

0.601

−0.02
(−0.12, 0.09)

0.759

0.015

−0.24
(−0.50, 0.02)

0.073

0.062

−0.16
(−0.38, 0.07)

0.172

0.012

−0.29
(−0.62, 0.05)

0.096

0.999

−0.04
(−0.21, 0.13) 2

0.633

0.609

−0.94
(−8.56, 6.68) 2

0.805

0.956

−0.05
(−0.97, 0.87)

0.915

0.046

−0.11
(−0.33, 0.55) 2

0.600

1

Descriptive statistics for continuous outcome I are presented using medians and quartiles (Q1 and Q3). 2 Regression analysis based on natural log (ln) transformation of outcome. All analyses adjusted for site (Hamilton, London)
and pre-pregnancy BMI categories: underweight to normal weight (BMI ≤ 24.9), overweight (BMI = 25.0–29.9),
obese (BMI = 30.9). Underweight and normal weight were grouped together due to a low number of observations
in the underweight category (n = 4).

3.5. Dietary and Physical Activity Measures
At baseline, diet scores based on PrimeScreen FFQ were similar between intervention
and control groups (mean ± SD; 18.7 ± 7.6 1 vs. 7.1 ± 8.7 (Figure 4)). In the intervention
group, diet scores improved significantly (p < 0.001) over baseline at 26–28 weeks gestation
(22.9 ± 6.1) and remained higher at the end of pregnancy (22.5 ± 6.9) (Figure 4) while scores
for the control group did not change (18.7 ± 7.7 and 18.7 ± 8.5) (Figure 4). Based on 3-day
food records, mean protein intake prior to randomization was similar between groups
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for the control group did not change (18.7 ± 7.7 and 18.7 ± 8.5) (Figure 4). Based on 3-day
food records, mean protein intake prior to randomization was similar between groups
(Table 6) but rose by design in the intervention group by 28% and was significantly higher
(Table 6) but rose by design in the intervention group by 28% and was significantly higher
than
thanthe
thecontrol
controlgroup
groupatatboth
both26–28
26–28weeks
weeks(MD
(MD ==15.0;
15.0;95%
95%CI
CI[8.1,
[8.1,21.9]
21.9]g/day)
g/day)and
and36–
3836–38
weeks
(MD
=
15.2;
95%
CI:
9.4,
21.1
g/day)
gestation
(Table
7).
Total
energy
intake
weeks (MD = 15.2; 95% CI: 9.4, 21.1 g/day) gestation (Table 7). Total energy intake
(~2160
kcal/day)
was
similar
between
treatment
groups
(Table
7)
and
across
pregnancy
(~2160 kcal/day) was similar between treatment groups (Table 7) and across pregnancy
(Table
(Table6).
6).

Figure4.4.Participant
ParticipantPrimeScreen
PrimeScreen healthy
inin
Intervention
(n =
andand
Control
Figure
healthydietary
dietarypractice
practicescores
scores
Intervention
(n69)
= 69)
Control
67)groups.
groups.
(n(n= =67)
Table6.6.Macronutrient
Macronutrient intake
intake and
at at
3 timepoints
across
pregnancy.
Table
andphysical
physicalactivity
activitymeasures
measures
3 timepoints
across
pregnancy.

Gestation
Gestation
Group
Group

Diet/Physical Activity
Diet/Physical Activity Measure
Measure
3-day Food Record Data
3-day Food Record Data
Energy intake; kcal/day

12–17
Weeks
26–28
12–17
Weeks
26–28 Weeks
Weeks
Intervention
Control
Control
Intervention
Control Intervention
Intervention
Control
Mean
(SD)
Mean
(SD)
Mean (SD)
Mean (SD)
n n= =115
n
=
117
n
=
84
nn==91
115
n = 117
n = 84
91

2148 1

1
2148
(491)
84.6
(491)
(22.5)
84.6
(22.5)

Energy intake; kcal/day
Protein intake; g/day

Protein
g/day
Bodyintake;
Media Data

2085
(312)
2085
7043
(2655)
(312)

Energy
Expenditure;
kcal/day
Body
Media
Data
DailyExpenditure;
step count
Energy
kcal/day
1

Daily step count

2084
(357)
2084
6588
(2545)
(357)

2195

2195
(423)
108.6
(423)
(26.8)
108.6
(26.8)

2152
(338)
2152
6938
(2717)
(338)

2129

2129
(499)
87.9
(499)
(23.2)
87.9
(23.2)

2127
(387)
2127
6337
(2647)
(387)

Intervention
Control
Intervention
Control
Mean
(SD)
Mean (SD)
n
=
91
n = 89
n = 91
n = 89

2203
2203
(545)
104.4
(545)
(25.4)

2152
2152
(496)
87.4
(496)
(23.2)

2185
(375)
2185
5538
(2490)
(375)

2157
(325)
2157
5563
(2208)
(325)

104.4
(25.4)

Values are
mean (SD) based6588
on raw data of available
deviation.
7043
6938 dietary records.
6337 SD = Standard5538

(2655)
1

2149

2149
(539)
87.5
(539)
(23.8)
87.5
(23.8)

36–38Weeks
Weeks
36–38

(2545)

(2717)

(2647)

(2490)

87.4
(23.2)

5563
(2208)

Values are mean (SD) based on raw data of available dietary records. SD = Standard deviation.
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Table 7. Intervention effect on dietary and physical activity measures at 26–28 weeks and 36–38
weeks of gestation.
Outcome Measure 1

Intervention Effect As at 26–28 Week Gestation
Complete Case Analysis
Mean
Difference
(95%CI)

Energy Intake,
kcal/day
Missing
Protein Intake, g/day
Missing
Energy Expenditure,
kcal/day 2
Missing
Step count/day
Missing

60
(−59, 180)
66
21.3
(14.4, 28.1)
66
0.02
(−0.02, 0.06)
67
225
(−45, 1901)
67

ITT Analysis

Intervention Effect at 36–38 Week Gestation
Complete Case Analysis

p

Mean
Difference
(95%CI)

p

0.320

28
(−984, 154)

0.662

<0.001

15.0
(8.1, 21.9)

<0.001

0.337

<0.01 (−0.02,
0.02)

0.904

0.512

69
(−554, 692)

0.827

Mean
Difference
(95% CI) 1
56
(−83, 195)
61
19.2
(12.8, 25.5)
61
<0.01
(−0.04, 0.04)
94

−415
(−1056, 226)
91

ITT Analysis

p

Mean
Difference
(95% CI)

p

0.429

32
(−136, 200)

0.700

<0.001

15.2
(9.4, 21.1)

<0.001

0.922

<0.01
(−0.02, 0.02)

0.971

0.203

−315
(−900, 271)

0.286

1

Values based on 3-day food records and accelerometry measures adjusted for baseline (V1b) and design
variables (pre-pregnancy body mass index and site). 2 Regression analysis was based on the log transformation of
the outcome.

Based on accelerometry data, average daily step counts were similar between intervention and control groups throughout pregnancy (Tables 6 and 7) reducing to ~5550 steps/day
at late pregnancy (Table 6). The 10,000 step goal was achieved by only 9.1% of intervention
participants at 26–28 weeks gestation and 5.5% of participants at 36–38 weeks gestation.
Both groups spent about 50 min per day at baseline in moderate to vigorous physical
activity, but this declined to 38 min at the end of pregnancy (data not shown). The total
energy expenditure was similar between treatment groups (Table 7) and across pregnancy
from 12–17 to 36–38 weeks gestation averaging about 2100 kcal/day (Table 6).
4. Discussion
The BHIP structured and monitored diet with at least biweekly nutrition counselling
resulted in improvements in overall diet quality, higher protein intake (106 vs. 88 g/day),
and stable energy intake across pregnancy. The positive dietary response was not mirrored
in achieving the exercise goal of 10,000 steps which proved challenging. Mean daily step
counts remained similar across pregnancy between treatment groups and declined from
baseline to 36–38 weeks gestation with fewer than 10% of women achieving the target step
count despite continued encouragement and walking sessions accompanied by research
staff at the bi-weekly visits for the intervention group. Taken together, the observed changes
in nutritional practice in the intervention group were likely the explanation for the observed
51% greater chance of achieving a GWG within the current guidelines of the IOM [1] and a
mean lower total GWG of 1.45 kg compared to the control, although the differences were
not statistically significant.
Sensitivity analysis provided insights into the variation in outcome responses across
BMI categories. The normal weight BMI category had a higher achievement of GWG
within recommendations (49.2%) than overweight (10.3%) or obese (5.9%) women. This
parallels the finding of a RCT of a behavioral intervention in women (n = 358) from all
BMI categories wherein a significant main effect for BMI category for excessive GWG was
observed compared with all other weight-gain categories [28].
Cardiometabolic monitoring of blood glucose, blood pressure, and lipid profiles
showed similarity between intervention and control group and few abnormalities. Only
14% of women developed impaired fasting glucose, and few (n = 4) developed hypertension. In the complete case analysis, fasted blood LDL, total cholesterol, and CRP were
significantly lower in the intervention group but not likely of clinical significance.
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For infants, birth outcomes did not differ by treatment group. Birth weights were
appropriate for gestational age with only 6–10% in the >90th percentile range and 5–6% in
the <10th percentile range.
In interpreting our findings compared to other recent similar clinical trials, we observed that the proportion of women meeting the IOM GWG recommendations in the
BHIP study were higher than the prospective meta-analysis of 7 harmonized RCTs called
LIFE-Moms in the US in which only 17.6% in the intervention (compared to 33% in BHIP)
and 10.8% in the standard care group (compared to 22% in BHIP) attained GWG within the
IOM recommendations despite having a significant intervention effect in lower total weight
gain [29]. Further, the 1.45 kg total lower GWG in the intervention group was twice that
observed (−0.7 kg) for the intervention group reported in the individual participant data
(IPD) meta-analysis of diet and physical activity-based interventions [30] and similar to the
LIFE-Moms RCT of −1.58 kg [29]. The observed −1.45 kg lower GWG in our intervention
group represents a >10% difference of the expected gain using the IOM recommendation
of 11–16 kg for the normal weight BMI category. This could be considered a clinically
significant difference.
That the BHIP intervention did not impact maternal pregnancy outcomes is in line
with previous meta analyses of RCTs that found a treatment effect on GWG but not for
GDM, preeclampsia, or pregnancy-induced hypertension [31] and is also consistent with
prenatal lifestyle intervention studies in the United States [32] and Australia [33] and the
recent IPD-meta-analysis that showed a significant reduction in Cesarean section with the
intervention but not for GDM, hypertensive disorders, or preterm delivery [34]. The low
rates of GDM and pre-eclampsia may reflect the general good health of our study groups.
The infant birth outcomes in the BHIP study were also consistent with the majority of
previous meta-analysis reviews of diet and exercise interventions wherein no significant
differences were reported in infant birthweight, macrosomia, or prevalence estimates of
SGA and LGA infants [29,32,33,35], as well as a UK study in obese pregnant women in the
United Kingdom (n = 1555) [36] and in women of all BMI categories in Brazil (n = 639) [37].
The strategy of a multi-component intervention in pregnancy for GWG management
as designed in BHIP aligns with recommendations of a recent evidence review [38]. Further, this study addressed the identified under-reporting of intervention content or “active
intervention ingredients” for nutrition and exercise interventions by specific adherence measures [39]. The improved diet quality score and higher protein intake indicated adherence
to the structured and individualized dietary guidance with counselling in the intervention
group. The frequency of knowledge sharing and individualized guided support from
the study nutritionist, including a nutrition handbook, in addition to the provision of
self-selected low-fat dairy foods, were likely other motivating factors to improve dietary
practices in the intervention group.
Our results on physical activity measures align with a recent multi-component RCT in
which a goal of 10,000 steps per day was not attained out to late pregnancy [40]. Current
evidence-based Canadian pregnancy guidelines for physical activity during pregnancy
recommend at least 150 min of moderate-intensity exercise a week such as brisk walking,
accumulated over a minimum of three days, but do not specify a daily step count [41].
Since BHIP participants averaged 50 min/day of moderate to vigorous physical activity at
26–28 weeks gestation and 38 min/day at 36–38 weeks gestation, the recommended goal of
150 weekly minutes of physical activity for health benefits [40] would have been achieved
over 3 days in mid and 4 days in late pregnancy. The amount of time spent being physically
active by BHIP participants fell within recommendations in a recent evidence review [38].
Maintaining 10,000 daily steps may be an unreasonable goal, particularly in pregnancy;
and it has been questioned for use even in the non-pregnant population [42]. Many barriers
to achieving exercise recommendations for pregnancy include time limitations [43–45],
pregnancy-specific complications [44,45], or the misconception that exercise will cause
harm to their offspring [46,47].
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A major strength of the BHIP randomized trial was that it fulfilled many of the recently
recommended attributes of a multi-component approach to influencing GWG [38] and
addressed several methodological issues in studies on GWG noted to limit the strength of
evidence in a recent National Academy of Medicine discussion paper [3]. Examples include
initiation in early pregnancy; supervised physical activity; individualized intervention of
energy intake and diet plan with counselling; and GWG monitoring. Further, the two diet
assessment tools and accelerometry for quantitative physical activity measures employed
rather than questionnaires provided measures of fidelity and adherence to the prescribed
goals in the intervention group and comparison between groups. The BHIP study was
also conducted in a community setting and included all pBMI categories (except extreme
obesity), whereas many previous studies were targeted only to women with pregravid
obesity and/or overweight recruited through hospital clinics.
Limitations of the study relate to generalizability of the findings. The recruitment
sites were mostly primary care clinics of midwives or family doctors, and eligibility criteria
excluded women with limited comprehension of the English, with documented signs of
depression or a pre-pregnancy BMI above 40 kg/m2 . Our study population was mostly
Caucasian, holding a university degree, and a medium to high socio-economic status, thus
being representative of populations in the cities where recruitment occurred as they are
modern urban centers with universities, colleges, and major commerce. Finally, due to
funding constraints, we were not able to achieve the original sample size.
5. Conclusions
While the structured and monitored nutrition and exercise intervention did not result
in a statistically significantly greater proportion of women achieving recommended GWG
compared to usual prenatal care offered in our community, the observed lower GWG
of 1.45 kg in the intervention groups aligns with previous studies and may be clinically
significant. Improvements in dietary practices within the intervention group did lead to
healthier dietary practice scores and a higher protein intake as recently recommended [48].
The elements of the BHIP approach to improving nutrition may inform future studies
of nutrition in pregnancy; and the targets for nutrient intake such as energy for normal
weight, overweight, and obese women may need to be different [3]. While the exercise
goal was not attained, the average step counts and intensity observed were similar to other
studies [40], were within current guidelines [37], and were not associated with high blood
pressure. Perhaps the attained step counts reveal the limitations of capacity to exercise in
busy women during pregnancy and serve as realistic goals. Taken together, our results
can inform future guidance for feasible guidance on nutrition and physical activity in
pregnancy. As shown in the BHIP and other studies cited, achieving the current IOM
recommendations for GWG [1] (now over 12 years old) is not easily attainable for many
pregnant women. Our study demonstrated that a higher than recommended GWG was
not associated with a preponderance of adverse pregnancy or birth outcomes suggesting it
might be timely to re-visit the recommendations for ideal gestational weight gain.
Author Contributions: Conceptualization, S.A.A., S.M.P., E.K.H., M.F.M. and L.T.; data curation,
S.A.A.; formal analysis, S.A.A., K.D., T.V. and L.T.; funding acquisition, S.A.A., M.F.M., E.K.H., F.X.
and L.T.; investigation, S.A.A. and M.F.M.; methodology, S.A.A., L.T. and F.X.; project administration,
S.A.A.; supervision, S.A.A. and M.F.M.; writing—original draft, S.A.A.; writing—review and editing,
S.A.A., A.M., M.P., K.D., F.X., S.M.P., E.K.H., M.F.M. and O.W. All authors have read and agreed to
the published version of the manuscript.
Funding: This study was supported by competitive grants from CIHR (FRN 123347) and Dairy
Research Cluster Initiative (Dairy Farmers of Canada and Agriculture and Agri-food Canada (AAFC)),
and in-kind provision of milk, yogurt, and cottage cheese by GayLea Foods Coop & Ultima Foods,
Canada. M.P. was supported by a doctoral Vanier CIHR Canada Graduate Scholarship and a Career
Enhancement Program scholarship by the Canadian Child Health Clinician Scientist Program. The
funders had no role in the study design, data collection or analysis, decision to publish, or preparation
of the manuscript.

Nutrients 2022, 14, 810

17 of 19

Institutional Review Board Statement: The study was conducted according to the guidelines of
the Declaration of Helsinki, and approved by the Research Ethics Boards of Hamilton Health Sciences/McMaster University, Hamilton (REB Project#12-46, 2012), Western University, London (HSREB
103272, 2013), and Joseph Brant Hospital, Burlington (JBH 000-018-14, 2013) in Ontario, Canada.
Informed Consent Statement: Informed consent was obtained from all subjects involved in the study.
Data Availability Statement: The datasets used and analyzed for this manuscript can be made
available in the future from the corresponding author on reasonable request (Stephanie Atkinson at
satkins@mcmaster.ca).
Acknowledgments: We are grateful to our healthcare partners in the community who assisted in
recruitment, to our research staff and students who assisted with carrying out the protocol, and to all
of the participants who enthusiastically volunteered for the study.
Conflicts of Interest: S.A.A., M.P., A.M., E.K.H., M.F.M., O.W., F.X. and K.D. declare that they have
no conflict of interest. S.M.P. reports grants from US National Dairy Council, during the conduct
of the study; personal fees from US National Dairy Council, personal fees from US Dairy Export
Council, non-financial support from Enhanced Recovery, outside the submitted work. In addition,
Phillips has a patent Canadian 3052324 issued to Exerkine, and a patent US 20200230197 pending to
Exerkine but reports no financial gains.

References
1.
2.

3.
4.

5.
6.
7.
8.
9.

10.
11.
12.

13.

14.
15.

16.

Institute of Medicine. IOM—Weight Gain during Pregnancy; National Academies Press: Washington, DC, USA, 2009. Available
online: http://www.nap.edu/catalog/12584 (accessed on 12 June 2021).
Murray-Davis, B.; Berger, H.; Melamed, N.; Hasan, H.; Mawjee, K.; Syed, M.; Ray, J.G.; Geary, M.; Barrett, J.; McDonald, S.D.
Weight gain during pregnancy: Does the antenatal care provider make a difference? A retrospective cohort study. CMAJ Open
2019, 7, E283–E293. [CrossRef]
Siega-Riz, A.M.; Bodnar, L.M.; Stotland, N.E.; Stang, J. The Current Understanding of Gestational Weight Gain among Women
with Obesity and the Need for Future Research. NAM Perspect. 2020, 2020, E283–E293. [CrossRef] [PubMed]
Dzakpasu, S.; Fahey, J.; Kirby, R.S.; Tough, S.C.; Chalmers, B.; Heaman, M.I.; Bartholomew, S.; Biringer, A.; Darling, E.K.; Lee,
L.S.; et al. Contribution of prepregnancy body mass index and gestational weight gain to caesarean birth in Canada. BMC
Pregnancy Childbirth 2014, 14, 106. [CrossRef]
Durst, J.K.; Sutton, A.L.M.; Cliver, S.P.; Tita, A.T.; Biggio, J.R. Impact of Gestational Weight Gain on Perinatal Outcomes in Obese
Women. Am. J. Perinatol. 2016, 33, 849–855. [CrossRef] [PubMed]
Xu, Y.; Shen, S.; Sun, L.; Yang, H.; Jin, B.; Cao, X. Metabolic Syndrome Risk after Gestational Diabetes: A Systematic Review and
Meta-Analysis. PLoS ONE 2014, 9, e87863. [CrossRef]
Bellamy, L.; Casas, J.-P.; Hingorani, A.D.; Williams, D. Type 2 diabetes mellitus after gestational diabetes: A systematic review
and meta-analysis. Lancet 2009, 373, 1773–1779. [CrossRef]
Garovic, V.D.; August, P. Preeclampsia and the future risk of hypertension: The pregnant evidence. Curr. Hypertens. Rep. 2013, 15,
114–121. [CrossRef] [PubMed]
Siega-Riz, A.M.; Viswanathan, M.; Moos, M.-K.; Deierlein, A.; Mumford, S.; Knaack, J.; Thieda, P.; Lux, L.J.; Lohr, K.N. A
systematic review of outcomes of maternal weight gain according to the Institute of Medicine recommendations: Birthweight,
fetal growth, and postpartum weight retention. Am. J. Obstet. Gynecol. 2009, 201, 339.e1–339.e14. [CrossRef] [PubMed]
Eriksson, J.G.; Sandboge, S.; Salonen, M.K.; Kajantie, E.; Osmond, C. Long-term consequences of maternal overweight in
pregnancy on offspring later health: Findings from the Helsinki Birth Cohort Study. Ann. Med. 2014, 46, 434–438. [CrossRef]
Goldstein, R.F.; Abell, S.K.; Ranasinha, S.; Misso, M.; Black, M.H.; Li, N.; Hu, G.; Corrado, F.; Rode, L.; Kim, Y.J.; et al. Association
of Gestational Weight Gain with Maternal and Infant Outcomes. JAMA 2017, 317, 2207–2225. [CrossRef]
Goldstein, R.F.; Abell, S.K.; Ransinha, S.; Misso, M.L.; Boyule, J.A.; Harrison, C.L.; Black, M.H.; Li, N.; Hu, G.; Corrado, F.; et al.
Gestational weight gain across continents and ethnicity: Systematic review and meta-analysis of maternal and infant outcomes in
more than one million women. BMC Med. 2018, 16, 153. [CrossRef] [PubMed]
Perreault, M.; Atkinson, S.A.; Mottola, M.F.; Phillips, S.M.; Bracken, K.; Hutton, E.K.; Xie, F.; Meyre, D.; Morassut, R.E.;
Prapavessis, H.; et al. Structured diet and exercise guidance in pregnancy to improve health in women and their offspring: Study
protocol for the Be Healthy in Pregnancy (BHIP) randomized controlled trial. Trials 2018, 19, 691. [CrossRef] [PubMed]
Gardner, B.; Wardle, J.; Poston, L.; Croker, H. Changing diet and physical activity to reduce gestational weight gain: A metaanalysis. Obes Rev. 2011, 12, e602-20. [CrossRef] [PubMed]
Ronnberg, A.; Nilsson, K. Interventions during pregnancy to reduce excessive gestational weight gain: A systematic review
assessing current clinical evidence using the Grading of Recommendations. Assessment. Developmenmt and Evaluation
(GRADE) system. BJOG 2010, 117, 1327–1334. [CrossRef]
Streuling, I.; Beyerlein, A.; Rosenfeld, E.; Hofmann, H.; Schulz, T.; von Kries, R. Physical activity and gestational weight gain: A
meta-analysis of intervention trials. BJOG Int. J. Obstet. Gynaecol. 2011, 118, 278–284. [CrossRef]

Nutrients 2022, 14, 810

17.
18.

19.

20.
21.

22.
23.
24.
25.
26.

27.
28.

29.

30.
31.

32.
33.

34.

35.

36.

37.

38.

39.

18 of 19

Be Healthy in Pregnancy (BHIP) with Nutrition and Exercise. Available online: https://clinicaltrials.gov/ct2/show/NCT01689961
(accessed on 5 January 2022).
Health Canada. Prenatal Nutrition Guidelines for Health Professionals: Gestational Weight Gain—Canada.ca. 2010. Available
online: https://www.canada.ca/en/health-canada/services/canada-food-guide/resources/prenatal-nutrition/eating-wellbeing-active-towards-healthy-weight-gain-pregnancy-2010.html (accessed on 12 June 2021).
Health Canada. Pregnancy Weight Gain Calculator—Nutrition and Healthy Eating—Health Canada. 2011. Available online:
https://health.canada.ca/en/health-canada/services/food-nutrition/healthy-eating/prenatal-nutrition/pregnancy-weightgain-calculator.html (accessed on 12 June 2021).
Health Canada. Eating Well with Canada’s Food Guide. 2007. Available online: https://www.hc-sc.gc.ca/fn-an/alt_formats/
hpfb-dgpsa/pdf/food-guide-aliment/print_eatwell_bienmang-eng.pdf (accessed on 12 June 2021).
Josse, A.R.; Atkinson, S.A.; Tarnopolsky, M.A.; Phillips, S.M. Increased consumption of dairy foods and protein during diet and
exercise-induced weight loss promotes fat mass loss and lean mass gain in overweight and obese premenopausal women. J. Nutr.
2011, 141, 1626–1634. [CrossRef]
Davies, G.A.L.; Wolfe, L.A.; Mottola, M.F.; MacKinnon, C. Joint SOGC/CSEP clinical practice guideline: Exercise in pregnancy
and the postpartum period. Can. J. Appl. Physiol. 2003, 28, 330–341. [CrossRef]
Walji, R.; Wahoush, O.; Atkinson, S.A. Feasibility and Acceptance of a Novel Nutrition and Exercise Intervention to Manage
Excess Gestational Weight Gain: Focus group study in Ontario, Canada. Prim. Health Care 2013, 3, 2. [CrossRef]
Institute of Medicine. Dietary Reference Intakes for Energy, Carbohydrate, Fibre, Fat, Fatty Acid, Cholesterol, Protein and Amino Acids
(Macronutrients); National Academies Press: Washington, DC, USA, 2005.
Cox, J.L.; Holdenand, J.M.; Sagovsky, R. Detection of Postnatal Depression Development of the 10-item Edinburgh Postnatal
Depression Scale. Br. J. Psychiatry 1987, 150, 782–786. [CrossRef]
Rifas-Shiman, S.L.; Willett, W.C.; Lobb, R.; Kotch, J.; Dart, C.; Gillman, M.W. PrimeScreen, a brief dietary screening tool:
Reproducibility and comparability with both a longer food frequency questionnaire and biomarkers. Public Health Nutr. 2001, 4,
249–254. [CrossRef]
World Health Organization. WHO Child Growth Standards. Dev. Med. Child. Neurol. 2009, 51, 1002. [CrossRef]
Society of Obstetricians and Gynaecology of Canada. Society of Obstetricians and Gynaecologists of Canada—Gestational
hypertension—Pregnancy Info. The Society of Obstetricians and Gynaecologists of Canada. Available online: https://www.
pregnancyinfo.ca/your-pregnancy/special-consideration/diabetes-and-hypertension/ (accessed on 12 June 2021).
Peaceman, A.M.; Clifton, R.G.; Phelan, S.; Gallagher, D.; Evans, M.; Redman, L.M.; Knowler, W.C.; Joshipura, K.; Haire-Joshu, D.;
Yanovski, S.Z.; et al. Lifestyle Interventions Limit Gestational Weight Gain in Women with Overweight or Obesity: LIFE-Moms
Prospective Meta-Analysis. Obesity 2018, 26, 1396–1404. [CrossRef]
Frangakis, C.E.; Rubin, D.B. Addressing complications of intention-to-treat analysis in the combined presence of all-or-none
treatment-noncompliance and subsequent missing outcomes. Biometrika 1999, 86, 365–379. [CrossRef]
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